ALK Positive Inc. shared a post on LinkedIn:
“A highlight from AACR26 – our Executive and Medical Director, Dr. Ken Culver, had the honor of meeting Dr. Alice Tzeng, the inaugural recipient of the AACR-ALK Positive Lung Cancer Research Fellowship!
Dr. Tzeng is a Medical Oncology Fellow at Dana-Farber Cancer Institute, and her research focuses on understanding why some ALK+ lung cancers become resistant to lorlatinib – and how to overcome it. We couldn’t be more proud to support her work.”
Other Articles About ALK Positive Inc. on OncoDaily.